Cardiff Oncology, Inc. (CRDF)

NASDAQ

$0.95

$+0.02

(+2.42%)

Regular Market

Cardiff Oncology, Inc. (CRDF) Live Price Chart

Last updated: ⁦2026-10-21 19:03:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Cardiff Oncology, Inc. (CRDF) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.95, with a market capitalization of $68.90M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.76 to $3.31. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$68.90M
Open	$0.95
Day's High	$25.50
Day's Low	$0.76
Previous Close	$0.93
Volume	274.67K
Average Volume	737.50K
P/E Ratio	--
52-Week High	$3.31
52-Week Low	$0.76
Dividend Yield	--
Earnings Date	--

Cardiff Oncology, Inc. (CRDF) Stock Price Today

Cardiff Oncology, Inc. (CRDF) is currently trading at $0.95 as of 2026-10-21 19:01:00, up 1.77% ($0.02) from the previous close of $0.93

During today's regular trading session, CRDF has traded between $0.76 and $25.50, with a trading volume of 274.67K shares. The current price is near the lower end of today's range.

Cardiff Oncology, Inc. (CRDF) 7-Day Stock Price Change

Over the past seven days, Cardiff Oncology, Inc. (CRDF) moved from $1.04 to $0.95, representing a decline of 8.85% ($0.09).

The stock traded between $0.88 and $1.08 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 469.72 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

CRDF 52-Week Price Position

Position in Range: 7.5%

52W Low$0.76

52W High$3.31

CRDF is currently trading at $0.95, placing it 7.5% of the way from its 52-week low of $0.76 to its 52-week high of $3.31. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Cardiff Oncology, Inc. (CRDF)?

Cardiff Oncology Inc is a clinical-stage biotechnology company advancing cancer treatments focused on PLK1 inhibition, a validated oncology target with practice-changing potential. Its main asset, onvansertib, is a specific, oral PLK1 inhibitor currently being evaluated in a Phase 2 trial for first-line treatment of RAS-mutated metastatic colorectal cancer (mCRC), addressing a large, underserved patient population with high unmet need. Onvansertib is also under investigation in other PLK1-driven cancers through ongoing investigator-initiated trials and has shown robust single agent clinical activity in hard-to-treat tumors. By targeting tumor vulnerabilities, to overcome treatment resistance and deliver improved clinical outcomes for patients.

Cardiff Oncology, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	31
Exchange	NASDAQ
Company Website	https://www.cardiffoncology.com

How to Buy Cardiff Oncology, Inc. (CRDF) Stock on MEXC

Eligible investors can buy real shares of Cardiff Oncology, Inc. (CRDF) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CRDF and Place Your Order

Open the RealStocks trading page and search for CRDF. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Cardiff Oncology, Inc. (CRDF) stock price today?

Cardiff Oncology, Inc. (CRDF) is currently trading at $ 0.95, up 1.77% ($0.02) from the previous close of $ 0.93. Intraday prices update in real time during regular trading hours.

2.Is CRDF stock going up or down today?

As of 2026-10-21 19:01:00, CRDF is trading at $ 0.95, up 1.77% ($0.02) from its previous close of $ 0.93. The stock has traded between $ 0.76 and $ 25.50 during today’s regular session. Past price movements do not guarantee future results.

3.What is CRDF pre-market price?

As of 2026-10-21 19:01:00, CRDF is trading at $ 0.94 in pre-market trading, up 1.02% ($0.01) from the previous close of $ 0.93. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CRDF after-hours price?

As of 2026-10-21 19:01:00, CRDF is trading at $ 0.95 in after-hours trading, up 1.45% ($0.01) from the regular-session close of $ 0.93. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CRDF stock trading now?

CRDF trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CRDF sit relative to its 52-week high and low?

Over the past 52 weeks, CRDF has traded between a low of $ 0.76 and a high of $ 3.31. At $ 0.95, the stock is positioned 7.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Cardiff Oncology, Inc. in?

Cardiff Oncology, Inc. (CRDF) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Cardiff Oncology, Inc.'s market capitalization and where is it listed?

Cardiff Oncology, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 68.90M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CRDF valued in terms of P/E ratio and EPS?

CRDF trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.52. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Cardiff Oncology, Inc. pay a dividend?

Cardiff Oncology, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.